Cambridge Consultants Investments

Cambridge Consultants has invested in 4 companies and its latest investment was Evonetix on Feb 06, 2023

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Evonetix is an England-based synthetic biology company that develops and commercializes DNA synthesis for healthcare, pharmaceuticals and data storage markets.
$24M
Feb 06, 2023
-
Evonetix is an England-based synthetic biology company that develops and commercializes DNA synthesis for healthcare, pharmaceuticals and data storage markets.
$30M
Mar 01, 2020
-
Evonetix is an England-based synthetic biology company that develops and commercializes DNA synthesis for healthcare, pharmaceuticals and data storage markets.
$12.3M
Jan 29, 2018
-
Aveillant develops and provides holographic radar technologies for air traffic control and surveillance applications.
$10M
Apr 07, 2014
Nov 01, 2017

Frequently Asked Questions about Cambridge Consultants

  1. What is Cambridge Consultants investing in?

    Cambridge Consultants has invested in 4 companies including Evonetix, Evonetix and Evonetix
  2. What company did Cambridge Consultants invest in?

    Cambridge Consultants invested in a total 4 companies including Evonetix, Evonetix and Evonetix
  1. What are the top 4 investments by Cambridge Consultants?

    The top companies in which Cambridge Consultants invested are Evonetix, Evonetix, Evonetix and Aveillant